Help us maintain the quality of our job listings. If you find any issues with this job post, please let us know.
Select the reason you're reporting this job:
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs.
Minimal Residual Disease (MRD) Clinical Development Manager (REMOTE)
Overview
Myriad Genetics is a genetic testing company that provides actionable health information, empowering patients and their families to make critical and timely healthcare decisions, whether they’re evaluating risk for cancer, thinking about starting a family, or in search of more effective mental health treatment.
The Minimal Residual Disease (MRD) Clinical Development Manager plays an integral role in product and clinical development and adoption by maximizing the clinical and scientific evidence base for the oncology-related portfolio of products, with a main focus on minimal residual disease (MRD).
This role in the R&D department works across multiple departments to lead clinical and scientific studies and partnerships to support the clinical application and implementation of MRD.
A successful candidate has deep knowledge of the oncology space and cancer genetic testing, a demonstrated track record in clinical research, established relationships with oncology research networks, an understanding of the evidence required for guidelines support and payer coverage, scientific and/or clinical expertise in molecular diagnostics, experience in working with multidisciplinary teams, and experience in the industry/biotech setting. The candidate has an intuition for the future direction of cancer genetic testing and creative ideas for accelerating evidence development and test utilization.
Responsibilities
Assist in creating the evidence development strategy to drive the adoption of new and existing oncology products, primarily MRD, informed by medical society guidelines, coverage landscape, scientific capabilities, and the customer landscape.
Lead or assist in research initiatives to drive evidence development for MRD through clinical studies
Seek out, assess, and implement external partnerships to generate evidence on MRD clinical validity, utility, and effectiveness in target populations
Collaborate with the Real-World Evidence, Clinical Operations, and Scientific Communications teams on study design and execution, manuscripts, and other scientific presentations of MRD research
Work closely with stakeholders in R&D, Technology, and Commercial to ensure that the evidence development strategy aligns with scientific, technological, and commercial aims and capabilities of the company
Qualifications
Advanced clinical/scientific degree (MS, MD, or PhD) or relevant training with at 5-7 years of experience in oncology/cancer genetics; laboratory and/or industry experience preferred
Experience conducting clinical research and evidence development, track-record of peer reviewed publications preferred
Well-versed in scientific literature, guidelines, and other sources of information related to oncology/cancer genetics products
Established relationships with key opinion leaders in oncology preferred
Experience managing complex projects
Experience working collaboratively and cross-functionally
Excellent writing, communication, and presentation skills
A sense of eagerness to contribute to a supportive, interdisciplinary, motivated team
#REMOTE
Required profile
Experience
Level of experience:Senior (5-10 years)
Industry :
Biotech: Biology + Technology
Spoken language(s):
English
Check out the description to know which languages are mandatory.